Search

everythinglearnresearchcommunity

for

Search:↓

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Spironolactone is effective and safe for treating acne with minimal side effects.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

We need better research to improve alopecia treatment and patient care.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Long-term use of pyrithione zinc shampoos remains effective for scalp seborrheic dermatitis, with decreased effectiveness likely due to not following treatment instructions rather than the treatment itself.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Dermatologists are more comfortable and proactive in treating male pattern hair loss than primary care physicians.

Combining systemic and topical treatments, guided by weekly fungal cultures, effectively treats cat ringworm.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Regenerative medicine is effective and safe for treating vitiligo.